BTAL AGFiQ U.S. Market Neutral Anti-Beta Fund

USD 18.12 0.00 0
Icon

AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) Stock Analysis and Price Targets

ETF | Market Neutral | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 18.12

0.00 (0.00)%

USD 0.24B

0.08M

N/A

N/A

Icon

BTAL

AGFiQ U.S. Market Neutral Anti-Beta Fund (USD)
ETF | NYE
USD 18.12
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.24B

N/A

USD 18.12

AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) Stock Forecast

N/A

Based on the AGFiQ U.S. Market Neutral Anti-Beta Fund stock forecast from 0 analysts, the average analyst target price for AGFiQ U.S. Market Neutral Anti-Beta Fund is not available over the next 12 months. AGFiQ U.S. Market Neutral Anti-Beta Fund’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AGFiQ U.S. Market Neutral Anti-Beta Fund is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, AGFiQ U.S. Market Neutral Anti-Beta Fund’s stock price was USD 18.12. AGFiQ U.S. Market Neutral Anti-Beta Fund’s stock price has changed by -0.49% over the past week, -0.11% over the past month and -12.29% over the last year.

No recent analyst target price found for AGFiQ U.S. Market Neutral Anti-Beta Fund
No recent average analyst rating found for AGFiQ U.S. Market Neutral Anti-Beta Fund

Company Overview AGFiQ U.S. Market Neutral Anti-Beta Fund

The fund will invest primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors. It will construct a dollar neutral portfolio of long and short positions of U.S. equities by investing primarily in...Read More

http://www.agfiq.com

N/A

N/A

N/A

USD

USA

13/09/2011

DJ US Thematic Mkt Neut Anti-Beta TR USD

BBgBarc US Agg Bond TR USD

1.43 %

Adjusted Closing Price for AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL)

Loading...

Unadjusted Closing Price for AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL)

Loading...

Share Trading Volume for AGFiQ U.S. Market Neutral Anti-Beta Fund Shares

Loading...

Compare Performance of AGFiQ U.S. Market Neutral Anti-Beta Fund Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BTAL

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 1

  • BBgBarc US Agg Bond TR USD

  • 2

  • 15.98

  • 0.00

  • 0.16

  • 7.43%

  • 5.24%

  • -1.46%

  • 0%

Stocks Similar To AGFiQ U.S. Market Neutral Anti-Beta Fund (Sector: Market Neutral )

Symbol Name Mer Price(Change) Market Cap
MNA
IQ Merger Arbitrage ETF 0.77 % 0.00 (0.00%) USD0.29B

ETFs Containing BTAL

Symbol Name BTAL's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) Stock

Stock Target Advisor's fundamental analysis for AGFiQ U.S. Market Neutral Anti-Beta Fund's stock is Slightly Bearish.

BTAL stock's dividend yield is 5.73%. Our analysis grades BTAL stock's dividend yield at A+. This means that BTAL stock's dividend yield is above 100% of the stocks in the Market Neutral sector in the NYE exchange. Based on this BTAL may be a good dividend stock for its sector.

Unfortunately we do not have enough data on BTAL's stock to indicate what its average analyst target is.

BTAL stock's Price/Earning ratio is 20.90. Our analysis grades BTAL stock's Price / Earning ratio at A+. This means that BTAL stock's Price/Earning ratio is above 0% of the stocks in the Market Neutral sector in the NYE exchange. Based on this BTAL may be undervalued for its sector.

The last closing price of BTAL's stock was USD 18.12.

The most recent market capitalization for BTAL is USD 0.24B.

Unfortunately we do not have enough analyst data on BTAL's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains AGFiQ U.S. Market Neutral Anti-Beta Fund's stock.

Sorry, we do not have any data on the number of employees for AGFiQ U.S. Market Neutral Anti-Beta Fund.

Sorry we do not have any infomation available on AGFiQ U.S. Market Neutral Anti-Beta Fund's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...